ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.785,50
-0,44%
S&P 500
5.105,01
-0,22%
US Dollar vs BRL
5,1656
0,92%
Bitcoin
61.186,45
-4,15%
Brent Oil
86,665
-0,71%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Natera Inc (NTRA)

  7. Natera Inc (NTRA) Notícias

NTRA Natera Inc

94,04
0,00 (0,00%)
Pré-mercado
Última atualização: 10:25:20
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Natera Inc NTRA NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,00 0,00% 94,04 10:25:20
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
94,04
mais cotações »

Notícias Recentes

Data Hora Fonte Título
22/04/202409:00BWNatera Announces Significant Milestone with 200+..
11/04/202409:00BWNatera Announces Publication of Largest Prospective dd-cfDNA..
08/04/202409:00BWNatera Announces New Data From Two Studies Extending the..
05/04/202408:00BWNatera Announces Positive Surveillance Analysis from the..
01/04/202409:00BWNatera and Alliance for Clinical Trials in Oncology Announce..
18/03/202408:00BWNatera Announces Phase III Randomized CIRCULATE Trial in..
14/03/202409:00BWNew KDIGO Guideline Supports Genetic Testing for the..
12/03/202409:00BWNatera to Present New Data at the 2024 SGO Annual Meeting on..
07/03/202410:00BWNatera Announces Commercial Coverage for Prospera™ Kidney..
29/02/202410:00BWNatera to Participate in March Investor Conferences
28/02/202418:05BWNatera Reports Fourth Quarter and Full Year 2023 Financial..
27/02/202410:00BWNatera Announces Next Phase of CareDx Patent Infringement..
26/02/202409:00BWMedicare Extends Coverage of Natera’s Signatera™ MRD Test to..
20/02/202410:00BWNatera Announces Fourth Quarter and Fiscal 2023 Earnings..
05/02/202410:00BWNew Study Validates Signatera™ in Endometrial Cancer
30/01/202409:00BWNew Publication Demonstrates Signatera’s Ability to Risk..
29/01/202409:00BWJury Rules in Favor of Natera in Patent Infringement Lawsuit..
25/01/202409:00BWNature Medicine Publishes Two Studies Highlighting..
22/01/202409:00BWNatera Acquires Reproductive Health Assets from Invitae
18/01/202410:00BWNatera to Present New Data from the CIRCULATE-Japan and..
16/01/202419:17BWNatera Provides Update on Ravgen Trial
09/01/202409:00BWNatera Announces Preliminary Fourth Quarter and Full Year..
29/12/202310:00BWNatera to Participate in the 42nd Annual J.P. Morgan..
28/12/202301:48BWNatera Wins Preliminary Injunction in Patent Infringement..
21/12/202310:00BWNatera Announces New Study Highlighting the Benefits of..
11/12/202314:50BWDelaware Court Denies CareDx’s Motion for Summary Judgment..
06/12/202310:30BWNatera Presents New Signatera™ MRD Data Across Breast Cancer..
14/11/202310:00BWNatera Announces Real-World Data Collaboration with Merck
08/11/202318:05BWNatera Reports Third Quarter 2023 Financial Results
08/11/202311:10BWNatera Announces Randomized, Phase III TREAT ctDNA Trial in..
07/11/202310:30BWNatera to Participate in November Investor Conferences
02/11/202309:30BWNatera’s Landmark RenaCARE Study Demonstrates Significant..
22/10/202314:00BWUpdated Data from CIRCULATE-Japan Presented at ESMO 2023..
20/10/202310:00BWNatera to Report its Third Quarter 2023 Results on November..
19/10/202310:00BWNatera Recognized on U.S. News & World Report’s 2024 Best..
16/10/202310:00BWNatera to Present New Signatera™ MRD Data at ESMO 2023,..
04/10/202310:00BWNew MRD Publication in Unresectable Stage I-III Lung Cancer..
03/10/202317:43BWSupreme Court Denies CareDx Request for Appeal in Patent..
02/10/202310:00BWNatera Submits First PMA Module to the FDA for Signatera™
18/09/202310:00BWNatera Announces Senior Leadership Appointments
14/09/202310:00BWNatera Announces Expanded I-SPY 2 Collaboration to Evaluate..
07/09/202301:09BWNatera Announces Pricing of $250 Million Follow-On Offering
06/09/202317:24BWNatera Launches Proposed Follow-On Offering
01/09/202310:00BWNatera to Participate in Upcoming Investor Conferences
16/08/202310:00BWNatera’s Prospera™ Lung Transplant Assessment Test Granted..
03/08/202317:05BWNatera Reports Second Quarter 2023 Financial Results
02/08/202317:05BWNatera to Participate in Canaccord Genuity 43rd Annual..
31/07/202314:39BWNatera Files Patent Infringement Suit Against NeoGenomics
28/07/202310:00BWNatera Announces Completion of Enrollment to the Randomized,..
27/07/202309:00BWNatera to Report its Second Quarter 2023 Results on August..

Seu Histórico Recente

NASDAQ
NTRA
Natera
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados